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Abstract
Purpose To investigate the dependence of the ciliary body length (CBL) on the axial length (AL) and to draw conclusions on
implications regarding safe pars plana access for intravitreal injections and vitreoretinal surgery.
Methods A total of 200 individuals (mean age 42 years, SD ± 15.4) were enrolled in the study. Objective refraction and ALwere
obtained. Spherical equivalent (SE) was calculated. Anterior segment optical coherence tomography (ASOCT) was used to
image and measure the CBL.
Results The mean SE was − 1.64 diopters (SD ± 3.15, range − 14.5 to + 9 diopters) and the mean AL was 24.19 mm (SD ± 1.65,
range 19.8–32.2 mm). There was a significant correlation between SE and AL (r2 = 0.62, p < 0.0001). Mean CBL correlated
significantly with age (r2 = 0.11, p < 0.0001), AL (r2 = 0.23, p < 0.0001) and SE (r2 = 0.25, p < 0.0001). The mean CBL was
3351μm (SD ± 459, range 2184–4451μm). Three separate groups were defined by their ALwith a normal AL group (AL 22.5 to
25 mm), a short AL group (AL < 22.5 mm) and a long AL group (AL > 25 mm). The mean CBL in the normal AL group was
3311 μm (SD ± 427), in the short AL group 2936 μm (SD ± 335) and in the long AL group 3715 μm (SD ± 365), and differed
significantly (p < 0.0001) when compared.
Conclusion For interventions requiring pars plana access (as an intravitreal injection or vitreoretinal surgery), an incision distance
of 3.5–4.0 mm posterior to the limbus is recommended. In our research, however, a difference of 0.77 mm inmean CBL between
the group with short AL and the group with long AL is demonstrated, implying that the mean CBL in very short and very long
eyes differs significantly. These findings suggest that the AL should be taken into account for pars plana access and that it would
be advisable to prefer the shorter or longer recommended distance (3.5 and 4.0 mm, respectively) from the limbus, which
correlates with the AL. If AL is > 25 mm, a distance of 4.0 mm from the limbus should be chosen; and if AL is < 22.5 mm, a
distance of 3.5 mm seems adequate.
Trial registration number and date NCT00564291, 27 Nov 2007
Key messages
The recommended incision distance of 3.5 – 4.0 mm from the limbus for safe pars plana access is based on the ciliary 
body length.
The ciliary body length, measured in vivo with anterior segment OCT, varies
significantly among different sized eyes with different axial lengths.
In very short or long eyes, the ciliary body length should therefore be taken
into account when performing intravitreal injections or vitreoretinal surgery.
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Introduction
The ciliary body (CB) is located posterior to the iris [1]. It is
composed of two parts, the pars plicata and the pars plana. The
pars plicata forms the anterior portion and is contiguous to the
posterior surface of the iris. It represents approximately one
quarter of the whole CB. The pars plana, the posterior portion
of the CB, is contiguous to the choroid at the ora serrata [2].
Intravitreal injections are applied through the pars plana of
the CB, 3.5–4.0 mm posterior to the limbus [3]. For children, a
distance of 0.5–3.5 mm from the limbus depending on the age
is used [4, 5]. For this reason, it is important to have a thor-
ough anatomical understanding of the CB and its extent.
One possible imaging modality to visualise these structures
is optical coherence tomography (OCT). OCT is a non-
invasive imaging modality obtaining high-resolution cross-
sectional images of anatomical structures of the eye [6]. In
1994, OCT was first used to image structures of the anterior
segment of the eye [7]. Until then, ultrasound biomicroscopy
(UBM) was the standard method to visualise anterior segment
structures [7]. Anterior segment optical coherence tomogra-
phy (ASOCT) has several advantages. It is a non-invasive,
non-contact technique and obtains a higher depth resolution
compared with UBM [8, 9]. Previous studies assessed data of
the CB using UBM [10, 11]. The ciliary body length (CBL)
showed a significant positive correlation with the axial length
(AL). Furthermore, CBL and ciliary body thickness (CBT)
were found to be significantly increased in the superior quad-
rant compared with the nasal, temporal and inferior quadrants
[12]. AL correlates with myopia: the higher the grade of my-
opia the longer the ocular bulb [13]. To analyse the CB in
patients with a wide range of refractive errors, especially in
myopic eyes, volume scans were performed in 4 quadrants
using ASOCT. The objective of this study is to evaluate the
total CBL (pars plicata + pars plana) using ASOCT in patients
with differing refractive error to fathom the implications for
interventions needing access to the pars plana of the CB, such
as intravitreal injections and vitreoretinal surgery.
Participants and methods
This study was conducted at the Department of Ophthalmology,
University Hospital of Bern, Bern, Switzerland. All procedures
used in this study were approved by the local Ethics Committee
of the University of Bern, Switzerland, and adhered to the tenets
of the Declaration of Helsinki. Over a period of 4 months (from
November 2017 to February 2018), 200 participants were re-
cruited for this prospective non-interventional study. From each
individual, written informed consent was obtained. Male and
female participants and patients aged > 18 years were acquired.
Eyes were excluded if they had intravitreal injections, history of
vitrectomy, pathologies of the sclera or macular pathologies.
Pseudophakic eyes (n= 8) were not excluded, as they did not
have surgery affecting the sclera. In each individual, primarily the
right eyewas included. If the right eye had to be excluded, the left
eye was included. Objective refraction was obtained using Nidek
ARK 1-s (Nidek CO. LTD, Aichi, Japan). The spherical equiv-
alent was calculated and used for further analysis. A spectral
domain ASOCT (Heidelberg Engineering GmbH, Heidelberg,
Germany) was used to image the CB and the anterior sclera
including the limbus. The ambient illumination was reduced to
a minimum to have the fewest interfering signal. To obtain im-
ages of the anterior segment in 4 quadrants, all participants were
asked to look at a fixation light that was moved from
inferotemporal (IT) to superotemporal (ST), inferonasal (IN)
and superonasal (SN).
To image a broad segment of the anterior structures of the
eye, the scanned area with a pattern size of 15° × 5° (8.3 ×
2.8 mm) was partially placed over the limbus. Each scanned
area included 11 B-scans, which were separated by 277 μm
from each other. Automatic real-time (ART) function was set
at 36 frames to achieve better resolution.
CBL was measured using the Heidelberg software
(Heidelberg Eye Explorer Heyex 2, version 6.5.5.0, Heidelberg
Engineering, Heidelberg, Germany). Measurements of the CBL
were performed by two independent examiners (K.S. and A.J.)
in 3 different B-scans for each quadrant after which the measure-
ments were averaged. The mean calculated intraclass correlation
coefficient (ICC) between the individualmeasurements was 0.91
(95% confidence interval, 0.89–0.93). The ciliary body length
was measured as the distance in a straight line from the deepest
point of the iridotrabecular angle to the last discernible mass of
the ciliary body. The last discernible mass was defined as the
region where there was no gap between the ciliary epithelium
and the sclera and, after this point, the ciliary body epithelium or
internal limiting membrane/retina continued parallel to the sclera
(see Table 1 for an overview of the values and Fig. 1 for a
representative illustration). IOL Master 500 (Carl Zeiss
Meditec, Inc., Dublin, CA, USA, software version 7.7.4.0326)
was used to measure AL. Five separate measurements of AL
were averaged.
For statistical analysis, Prism 8 (GraphPad Software, Inc.,
La Jolla, CA, USA) was used. Data was analysed for normal-
ity using the d’Agostino-Pearson omnibus K2 test. AL and SE
did not show a Gaussian distribution. Correlations including
these parameters were done using Spearman’s rank correla-
tion. For comparison of groups, ANOVA was used after ver-
ifying normality. A p value of 0.05 or smaller was considered
statistically significant.
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Results
Of the 200 eyes enrolled in the study, 104 individuals were
females and 96 males. The eyes in which one or multiple
quadrants of the ciliary body could not be measured because
important landmarks were not discernible or cut off were ex-
cluded. A total of 21 eyes were excluded, with 179 eyes left
for CBL analysis.
Themean agewas 42 years (SD ± 15.4, range 19–79 years).
The mean body height was 173 cm (SD ± 8.9, range 148–
200 cm) and the mean SE was − 1.64 diopters (SD ± 3.15,
range − 14.5 to + 9 diopters). The mean AL was 24.19 mm
(SD ± 1.65, range 19.8–32.2 mm) (Table 1). There was a
significant correlation between SE and AL (r2 = 0.62, p <
0.0001) as well as between AL and body height (r2 = 0.02,
p = 0.0002).MeanCBL correlated significantly with age (r2 =
0.11, p < 0.0001), AL (r2 = 0.23, p < 0.0001) and SE (r2 =
0.25, p < 0.0001) (Fig. 2). The mean CBL was 3351 μm (SD
± 459) with a range from 2184 to 4451 μm. In a subgroup of
40 patients, the mean distance between the limbus (Fig. 1,
“L”) and the ciliary body (Fig. 1, “ACA”, which represents
the starting point of our ciliary body length measurement)
measured 795 μm. Comparing the CBL in the 4 quadrants,
the superior-temporal quadrant showed the largest CBL with
3462 μm (SD ± 497.9), and the anatomically opposing
inferonasal quadrant showed the smallest CBL with
3238 μm (SD ± 506). In the superonasal and inferotemporal
quadrants, we measured very similar-sized CBLs with
3369 μm (SD ± 461) and 3314 μm (SD ± 540), respectively.
Three separate groups were defined by their AL with a
normal AL group (AL ranging from 22.5 to 25 mm, n =
123), a short AL group (AL < 22.5 mm, n = 20) and a long
AL group (AL > 25 mm, n = 36). We found a mean CBL in
the normal AL group of 3311 μm (SD ± 427), in the short AL
group of 2936 μm (SD ± 335) and in the long AL group of
3715 μm (SD ± 365). After verifying a normal distribution
using the d’Agostino and Pearson omnibus K2 normality test,
we analysed and compared the 3 groups using a one-way
ANOVA test. The mean CBL showed significant differences
between the 3 groups (p < 0.0001, Fig. 3). (For an overview of
the groups, see Table 2.) In a subanalysis concerning the 4
quadrants (ST, SN, IT and IN), we also found significant
differences between the 3 groups for each quadrant’s CBL
(Fig. 4).
Fig. 1 Two representative ASOCT images with infrared superficial en
face images of the conjunctiva and underlying sclera near the limbus on
the left (A) with the arrow indicating the cross section of the anterior
segment optical coherence tomography (ASOCT) image on the right.
The limbus (L) and the size of the ciliary body (CBL) are marked as
measured on image (B), which illustrates the measured length of the
ciliary body (in red), the ciliary body (CB) itself and the anterior chamber
angle (ACA). L, limbus; CBL, ciliary body length; C, cornea; Scl, sclera;
Conj, conjunctiva; SS, scleral spur; Art, artefact (inverted iris)
Table 1 Clinical characteristics of the enrolled subjects including
ciliary body length (CBL) measurements with standard deviation (SD)
and range
Mean ± SD Range
Age (years) 42.3 ± 15.4 19.1–79.6
Height (cm) 172.5 ± 8.9 148–200
Spherical equivalent (dpt) − 1.64 ± 3.15 − 14.5–9.0
Axial length (mm) 24.19 ± 1.65 19.8–32.16
CBL mean (μm) 3351 ± 458.9 2184–4451
CBL superotemporal (μm) 3462 ± 497 2007–4734
CBL superonasal (μm) 3369 ± 460.5 2154–4716
CBL inferotemporal (μm) 3314 ± 539.6 1899–4829
CBL inferonasal (μm) 3238 ± 506 1836–4615
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Discussion
A significant correlation between the mean CBL and AL was
found. This finding suggests that the ciliary body grows or
stretches as does the sclera in case of globe elongation in
myopia. This is an interesting finding, as the size of the ciliary
body dictates the position of the pars plana and thus the ana-
tomic site of surgical entrance for posterior segment surgery
and intravitreal injections. A distance posterior to the limbus
of 3.5 to 4.0 mm is considered a safe distance to be sure to
pierce the pars plana and not damage the retina or the lens
[14]. However, in our cohort, a range of 2170 μm or 2.2 mm
between the shortest and longest CBL and a difference of
770 μm or 0.77 mm in mean CBL between the group with
short AL and the group with long AL are demonstrated. To
put things in perspective, this range of 0.77 mm exceeds the
variation of 0.5 mm between the lower and upper limits of the
advised safety distance from the limbus (3.5–4.0 mm). This
leads to the conclusion that the CBL should be taken into
account for a safe pars plana access. The AL seems to repre-
sent an easy and quickly measurable surrogate marker of the
CBL in light of the significant correlation with CBL in our
sample. We would argue that in case of short eyes (AL <
22.5 mm), one should err on the short side of the recommend-
ed distance (3.5 mm) and in a long eye (AL > 25 mm) on the
long side (4.0 mm). A limitation of this approach is the vari-
ability of the injection site in daily clinics. As the distance
from the limbus is measured by hand with an appropriate
instrument and marked by impression or by a pen by the
operating surgeon, there will be some variability in the dis-
tance, especially in the face of the small room for error when
marking distances in fraction of millimetres. This variability
of the injection site can be depicted by infrared imaging,
whereby the injection points can be easily defined and show
amarked spread [15]. Therefore, it will be difficult to put these
miniscule changes of distance into practice.
Fig. 2 Correlations of the mean ciliary body length (CBL) with age, axial
length (AL) and spherical equivalent (SE) from left to right, which
showed a significant linear correlation. The Y-axis represents in all 3
graphs themean ciliary body length (CBL). The 3 AL groups are depicted
in colour on each graph (colour association is depicted on the vertical bar
on the right)
Fig. 3 Graph showing the 3 groups defined by their axial length (short,
normal and long) and the correspondingmean ciliary body lengths (CBL)
of the individual eyes on the left with 3 anterior segment optical coher-
ence tomography (ASOCT) slides on the right illustrating the CBL mea-
surements. Each ASOCT image belongs to one sample of the 3 groups,
whereby its exact position on the graph is indicated with thin lines. (A)
ASOCT image of an eye in the long AL (> 25 mm) group with a rather
long CBL. (B) ASOCT image of an eye in the moral AL (22.5–25 mm)
group with a normal-sized CBL. (C) ASOCT image of an eye in the short
AL (< 22.5 mm) group with a fairly short CBL
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A further limitation of our approach is that in our sample
size of 200 eyes, we only had a few outliers (n = 20 for the
short AL group and n = 36 for the long AL group) reaching or
surpassing the aforementioned cut-offs. The reported informa-
tion about CBL varies greatly in the literature. Data from
autopsy reports range from 4.5 to 6.3 mm [16–18]. A study
measuring the CBL using UBM found a mean ciliary body
length of 5.43 mm (SD ± 0.58, range 4.0–6.4 mm) [12]. In
comparison, our results came in significantly shorter (mean
3351 μm, range 2184–4451). There are various possible ex-
planations for these shorter measurements. One would be false
measurements. As measurements were conducted by 2 inde-
pendent examiners and the individual measurements in 3 dif-
ferent B-scans reached an ICC of 0.91, we deemed this pos-
sibility unlikely. One explanation could be varying definitions
regarding anatomic landmarks. We measured from the
iridocorneal angle to the last discernible mass of the pars plana
(see Figs. 1 and 3). However, it is possible that we measured
only the pars plicata and omitted inclusion of the pars plana
because of reasons of visibility in the OCT image. In this
context, it should be mentioned that the iridocorneal angle lies
more posteriorly than the external surgical limbus, which is
used as landmark to determine the correct intravitreal injection
site. In a subgroup of 40 patients, we measured this distance to
be 795 μm in our cohort. A third possibility is a different
imaging technique used across these studies. Previously pub-
lished literature used fixated tissue [16–18] or UBM [12],
whereby the measurements started from the scleral spur and
not the iridocorneal angle and additionally have taken the
curvature of the eye into account. Another possibility are mea-
surement artefacts due to these more invasive or manipulative
techniques. Through fixation of tissue in formalin, shrinkage
may be induced [19]. In UBM, slight touching, and thereby
impression of the sclera, is necessary which may have impli-
cations on measured length. In theory, ASOCT provides the
most unbiased in vivo examination technique. However, in
this case, the differences are more likely to originate from
the different landmarks used for the measurements as
highlighted previously. Despite the differences in total CBL,
the data is fairly consistent and is in keeping with previous
reports showing the greatest extent of the CBL in the superior
quadrant. Another limitation is that this data is only valid for
full-grown eyeballs as only adults > 18 years have been in-
cluded. For children, further data regarding the relation of the
CBL and AL has to be gathered to draw conclusions.
Intravitreal injections are nowadays a very common proce-
dure; and though complications are rare, they are potentially
vision threatening. Complications, which might occur due to
entry in the surrounding areas of the pars plana, are for exam-
ple rhegmatogenous retinal detachments (RRD) and vitreous
haemorrhages (VH) [20, 21]. Both adverse events can lead to
a drastic decline in vision.
Conclusion
Our findings suggest that the axial length should be taken into
account when choosing the exact distance to the limbus for
pars plana access in intravitreal injections and vitreoretinal
surgery to further reduce the risk of complications. A larger
number of pat ients is needed to give a def ini te
Fig. 4 Comparison of the mean ciliary body length (CBL) in the 4 quad-
rants (superotemporal, inferotemporal, inferonasal and superonasal) be-
tween the 3 groups, which are defined by their axial length (AL). Each
graph depicts the distribution of the mean CBL in the respective quadrant
between the 3 AL groups. Below the graphs, a colour-coded bar depicts
the colour association to the 3 AL groups
Table 2 Illustration of the 3 groups defined by axial length (AL) with mean values and standard deviations (SD). SE, spherical equivalent;CBL, ciliary
body length; n, number of subjects included in group
AL mean ± SD (mm) SE mean ± SD (dpt) CBL mean ± SD (μm)
Short AL group (< 22.5 mm, n = 20) 21.96 ± 0.58 1.54 ± 2.29 2936 ± 334.9
Normal AL group (22.5–25 mm, n = 123) 23.77 ± 0.66 − 0.86 ± 1.7 3311 ± 427.3
Long AL group (> 25 mm, n = 36) 26.53 ± 1.77 − 5.51 ± 3.75 3715 ± 364.8
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recommendation regarding an axial length–based injection
site, but for now these findings suggest that it would be advis-
able to prefer the shorter or longer recommended distance
posterior to the limbus (3.5 or 4.0 mm), which correlates with
the respective axial length. On the basis of our data in case of
an axial length of > 25 mm, a distance from the limbus of
4.0 mm should be chosen and in case of an AL of <
22.5 mm, a distance of 3.5 mm from the limbus seems
adequate.
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